EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Outcomes of Descemet Membrane Endothelial Keratoplasty Using a Preloaded Imported Graft

Minha Kim, Kang Hyun Kim, Hyung Keun Lee

Korean Journal of Ophthalmology · 2023

DOI: 10.3341/kjo.2023.0053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Korean Journal of Ophthalmology, 2023. Verfasst von Minha Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Descemet Stripping Endothelial Keratoplasty, Visual Acuity, Graft Survival, Endothelium, Corneal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Although the popularity of Descemet membrane endothelial keratoplasty (DMEK) is increased, there is still few clinical studies in Korea. In this study, we aimed to report the initial clinical outcomes of DMEK in patients followed up for more than 6 months.

Methods

A total of 96 eyes that underwent DMEK by a single surgeon for Fuchs endothelial corneal dystrophy, pseudophakic bullous keratopathy, or other indications were evaluated for best-corrected visual acuity (BCVA), endothelial cell density (ECD), central corneal thickness (CCT), postoperative complications, and graft survival.

Results

The postoperative BCVA significantly increased compared to the preoperative BCVA by 59.4% (1.00 ± 0.77 logarithm of the minimum angle of resolution vs. 0.67 ± 0.76 logarithm of the minimum angle of resolution, p < 0.001). The average preoperative ECD was 754 ± 382 cells/mm2, increasing to 1,333 ± 562 cells/mm2 at 3 months (76.8%, p < 0.001), 1,334 ± 632 cells/mm2 at 6 months (76.9%, p < 0.001), 1,121 ± 474 cells/mm2 at 12 months (48.7%, p = 0.024), and 972 ± 458 cells/mm2 at 24 months postoperatively (28.9%, p = 0.445). Compared to 3 months, the ECD declined by 15.9% at 12 months (p = 0.009) and 27.1% at 24 months postoperatively (p = 0.158). The average CCT was 675 ± 113 μm preoperatively, decreasing to 581 ± 102, 574 ± 101, and 594 ± 94 μm at 6, 12, and 24 months after DMEK, respectively (p < 0.001 between all follow-up time points). Allograft rejection was detected in three (3.1%) and 14 eyes (14.6%) underwent retransplantation at an average of 10.1 ± 8.4 months after DMEK.

Conclusions

DMEK is promising for maintaining corneal clarity, low postoperative complication rates, and stable graft longevity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Descemet Stripping Endothelial KeratoplastyVisual AcuityGraft SurvivalEndothelium, CornealHumansMaleFemaleAgedMiddle AgedFollow-Up StudiesRetrospective StudiesTreatment OutcomeCell CountFuchs' Endothelial DystrophyAged, 80 and overPostoperative ComplicationsTissue DonorsAdultRepublic of KoreaCorneal Diseases

Stichwörter der Autor:innen

Descemet membrane endothelial keratoplastyDescemet stripping automated endothelial keratoplastyEndothelial keratoplasty

Autor:innen und Institutionen

  • Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.

Zitieren

APA

Kim, M., Kim, K. H., & Lee, H. K. (2023). Clinical Outcomes of Descemet Membrane Endothelial Keratoplasty Using a Preloaded Imported Graft. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2023.0053

Vancouver

Kim M, Kim KH, Lee HK. Clinical Outcomes of Descemet Membrane Endothelial Keratoplasty Using a Preloaded Imported Graft. Korean Journal of Ophthalmology. 2023. doi:10.3341/kjo.2023.0053

BibTeX
@article{Kim2023,
  author = {Kim, Minha and Kim, Kang Hyun and Lee, Hyung Keun},
  title = {Clinical Outcomes of Descemet Membrane Endothelial Keratoplasty Using a Preloaded Imported Graft},
  journal = {Korean Journal of Ophthalmology},
  year = {2023},
  doi = {10.3341/kjo.2023.0053}
}
Kostenlos starten →